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202 C.A. Castro et al.mesoderm, or endoderm and to use this information for comparison to other teratomas. MRM provides rapid quantitative
imaging of intact teratomas that complements histology and identifies sites of interest for additional biological studies.
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Embryonic stem cells (ESCs) are defined by their ability to
self-renew and differentiate (Mountford, 2008). They are
characterized by their expression of specific markers (SSEA-
3/4, TRA, Oct4, Nanog, and others) (Hyun et al., 2008) and
their behavior in cell culture (differentiation into all three
germ layers). One of the stringent criteria for ESC lines
derived from human and nonhuman primates is their ability
to produce a teratoma tumor when injected into immuno-
compromised mice (Lanza, 2006). Additional stem cell types
have also been shown to produce teratomas including certain
germline stem cells and induced pluripotent stem cells (iPSC)
(Aleckovic and Simon, 2008). Other purported pluripotent
cells such as human embryonic and primordial germ cells and
amnion-derived cells have demonstrated in vitro multi-
lineage potential but have not shown teratoma formation in
vivo. A teratoma is a tumor strictly defined in pathological
terms by histological evidence of tissue types contributed by
each of the original three germ layers including ectoderm
(e.g., neuroepithelium, mature neuroglial tissue, skin),
mesoderm (e.g., smooth and skeletal muscle, connective
tissue, bone, and cartilage), and endoderm (e.g., lung and
intestinal mucosa, pancreas, liver) (Sternberg, 1989).
While at first glance, most teratomas appear as disorga-
nized masses with recognizable tissue types contributed
from the three basic germ layers and even focal organogen-
esis, little is known about the contribution of each germ layer
to the lesion and this information may hold important clues
to normal and abnormal development (Aleckovic and Simon,
2008; Damjanov, 1993; Lehman, 1980; Lehtonen et al., 1989;
Prelle et al., 2002). Studying the cellular and tissue milieu
within teratomas both in vivo and ex vivo would help in
beginning to answer the following questions: How much of
each specific tissue type is present? Do the tissues present
recapitulate normal development spatiotemporally? How are
the tissues present affected in type and quantity when
derived from ESCs that have been manipulated genetically
(induced chromosomal aberration, addition/deletion of
specific genes) and environmentally (that is, by drugs or
toxins, nutrients)? Do all ESC lines have the equal potential of
differentiating successfully into a specific cell type that
could be potentially used to treat specific diseases such as
diabetes or Parkinson disease? Because many of these
questions may begin to be addressed with more rigorous
examination of teratomas derived from ESCs, a recent
call to standardize the reporting criteria for teratomas
derived from ESCs and iPS cells has been proposed by Muller
et al. (2010). Their report underscored the lack of standards
for the production of teratomas, lack of reporting teratoma
formation, and the lack of consistency in reporting teratoma
results within publications using or deriving human ESCs or
iPSCs.
With this in mind, the aim was systematic evaluation and
careful comparison of teratomas derived from pedigreedprimate embryonic stem cells (nhpESCs) using two distinctive
modalities: magnetic resonance microscopy (MRM), a high-
resolution relative of magnetic resonance imaging (MRI), and
conventional semiquantitative histopathology. As clinical MR
image quality and resolution continue to improve, the use of
MRI in studies using embryonic stem cells transplantation will
allow for imaging of cellular trafficking and tissue/organ
development. Ensuring embryonic cell transplantation safety
by noninvasive detection and monitoring of atypical cellular
behaviors is also a pressing need (Cao et al., 2009). In
anticipation of these developments, we studied high-
resolution MR images of teratomas derived from nhpESCs
and correlated these MR images with careful and semiquan-
titative histopathology. No previous studies report ex vivo
MRM of teratomas, or attempt to correlate teratoma MR
images with histology.
We found that teratomas can be derived from injection of
immunodeficient mice with a high success rate using
pedigreed nhpESCs. Teratomas exhibited a broad range of
tissue amounts and tissue types derived from all germ layers
including yolk sac elements. MRM is a noninvasive in vivo and
ex vivo means to evaluate teratoma tissue content, tissue
volume data, and reliably identify specific tissue types for
longitudinal follow-up.Results
Since derived pedigreed nonhuman primate ESCs were
injected into mice to identify their pluripotency by ability
to form teratomas, we could utilize them for more detailed
analysis and comparison of tissue morphology and distribu-
tion within each teratoma and between teratomas using
histopathology and MRM.
Overall, no statistical differences were found for number
of blocks needed (crude estimate of size) when comparing all
teratomas between families and when comparing all
teratomas by gender. Eight teratomas were derived out of
12 injections (67% success) from 3 lines within one family,
compared to 19 teratomas derived from 22 injections (86%
success) of 4 lines in the other family. Two injections (106-
A1, A2) resulted in a moderate to poorly differentiated tumor
(see below) without evidence of teratoma formation. Two
injections from another line (306-C1, C2) produced a
dermoid cyst on one side (left testis) and no detectable
lesion from the other injection (right testis) (not shown).
Two injections did not produce a detectable lesion and one
produced a lesion with only two germ layers represented.
Table 1 shows characteristics of the three teratomas that
also underwent MRM.
We next compared in a semiquantitative fashion, the
relative contributions of each germ layer to the composition
of each teratoma using the scale provided under Methods.
Table 1 also demonstrates the median contributions of each
germ layer for each teratoma for which MRM was performed.
Table 1 Demographic and germ layer scores for teratomas
derived from pedigreed primate ESCs for which MRM was
performed
3006-C1 3006-C2 3106-B1
Gender F F M
Incubation time (days) 98 98 106
No. blocks/lesion 7 12 7
Ectoderm a 1 1 4
Mesoderm 5 3 1
Endoderm 1 1 1
a Scoring for percentage of germ layer tissues present: 1, 1-20%;
2, 21-40%; 3, 41-60%; 4, 61-80%; 5, 81-100%.
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type quantity with wide variations in ectodermal versus
mesodermal derivatives. However, in the overall analysis of
the teratomas, no differences were noted between families
for median contribution of germ layers or between sexes
either within families or between families.
Overall, approximately 23 different tissue types were
identified as derivatives of ectoderm (Figs. 1A–E), meso-
derm (Figs. 1F–O), and endoderm (Figs. 1P–T). Specific
tissues seen infrequently are shown in Figures 1U–Y.
Ectodermal derivatives included immature neuroglial
tissue represented by either neuroepithelial tissue composed
of stratified elongated cells with hyperchromatic oval nuclei
and pink cytoplasm arranged in ribbons and rosettes
(Flexner-Wintersteiner and Homer Wright) (A) or adjacent
cellular neuroglial tissue composed notably of small cells
with scant cytoplasm resembling neuroblasts (B). Cells with
granular brown pigment resembling retinal cells arranged in
rosettes were seen sporadically and in low quantity in some
teratomas associated with immature neural areas (B).
Mature neuroglial tissue was defined as tissue containing
mature neurons, glial cells, and background mature neuropil
resembling disorganized brain or areas with well-developed
ganglion (C, D). Skin was also present and in most cases
demonstrated a well-developed epidermis and adnexal
structures including in some cases hair follicles (E).
Mesodermal derivatives comprised the largest percentage
of tissues overall in these teratomas and consisted of muscle
(skeletal and smooth), fat, mesenchyme, cartilage, and bone
(F–O). Smooth muscle showed a consistent morphology
typical of mature smooth muscle found in the muscle layers
of the gastrointestinal tract. Well-defined and recognizable
smooth muscle was associated with glandular epithelium in
most cases and rarely seen in isolation arising from the
mesenchymal stroma. Often smooth muscle bundles were
found in layers recapitulating the two distinct layers seen in
the gastrointestinal tract of nonhuman primates, humans,
and other mammals. In other areas where more primitive
glandular epithelium was present, the surrounding stroma
had the appearance of immature smooth muscle (G).
Immature skeletal muscle (H) was delineated by multinucle-
ated myotubes, immature myofibers, and single rhabdomyo-
blastic cells interspersed in cellular mesenchymal stroma.
Mature skeletal muscle was apparent by long eosinophilic
myofibers showing striations (I). Skeletal muscle comprised a
large portion of the mesodermal component of teratoma
from the 3106 line (J). Immature and mature adipose tissuewas seen (K, L). The majority of adipose tissue was composed
of lobules of mature adipocytes with focal areas of immature
fat characterized by variation in size of adipocytes and the
presence of lipoblasts. Undifferentiated stroma demonstrat-
ed several morphological variants including cellular spindle
cell stroma with early collagenization (M), fibromuscular (N),
mixed collagenous/myxoid stroma, and densely fibrotic (not
shown). Within cellular areas numerous mitotic figures could
be readily identified, although atypical nuclear structures or
other malignant features were not seen. Bone and cartilage
were frequently present in many teratomas (O). Cartilage
displayed a range of morphology from cellular immature
cartilage generally associated with neuroglial regions to
more mature well-formed lobules of cartilage, some forming
structures resembling tracheal rings (see Fig. 2S).
Endodermal derivatives exhibited no specific morphology,
but had epithelium that generally lined cystic or glandular
spaces (structures having a lumen, not neuroepithelial) (P–
T). The epithelium varied considerably and included imma-
ture foveolar/intestinal type (P), primitive glandular (Q, R),
stratified (S), and primitive endodermal (yolk sac) type (T).
Ciliated and well-developed intestinal-type epithelium was
also present in some teratomas. Conspicuously missing from
all teratomas examined was evidence of well-developed
thyroid, liver, kidney, or pancreas.
Both injections of line 106 (A1, A2) resulted in tumors with
similar morphology best characterized as moderately to
poorly differentiated tumor (Figs. 2A–C) shown here to
illustrate one of the nonteratomatous lesions resulting from
ESC injections. These tumors exhibited both focal areas of
solid growth and areas of glandular differentiation. Inter-
estingly, most of the tumor cells exhibited a mixed epithelial
and mesenchymal phenotype by expression of cytokeratin
and vimentin (Figs. 2D and E, respectively). Scattered
periglandular cells demonstrated an immunophenotype
reminiscent of myoepithelial cells including expression of
smooth muscle actin, all muscle actin, and S100, respec-
tively (Figs. 2F, G, and H). These periglandular cells were
also negative for p63, a marker of basal cells in the sinonasal
tract, breast, and prostate. Tumor cells were negative for
PGP9.5, myogenin, and alpha-fetoprotein, making neuro-
blastic, skeletal muscle, or endodermal differentiation less
likely. Oct-4 (pluripotency marker) and p63 (epithelial
progenitor marker and marker of basal cells) did not show
characteristic nuclear staining in any tumor cells. Three lines
from 306 also formed undifferentiated/poorly differentiated
tumors, but exhibited abnormal karyotypes in the derived
lines.
As histopathological and immunohistochemistry analyses
require removal of the teratoma from the mouse, we
examined if we could utilize a noninvasive technique, i.e.,
MRM, for teratoma analysis. We performed MRM on two
teratomas from line 3006 and an additional teratoma from
line 3106. Figure 3 shows volumetric measurements and 3D
volume renderings of each teratoma made from MRM images.
Corresponding numerical measurements are shown in Sup-
plemental Table 1. All three teratomas had measured
volumes between 3.0 and 6.2 cc. A cystic volume fraction,
ranging between 1 and 3%, was found only in teratomas from
line 3006. In agreement with previous T2-weighted MRI of
teratomas, all cysts were high intensity and solid tissue had
heterogeneous contrast (Yamaoka et al., 2003; Monteiro
Figure 1 Collage of images of hematoxylin and eosin-stained tissue sections representing the range of tissues present in teratomas
from pedigreed nhpESC lines. A–E represent ectodermal derivatives, F–O mesodermal derivatives, P–T endodermal derivatives, and
U–Y interesting isolated findings. (A) Neuroepithelium showing stratified epithelium arranged in ribbons and rosettes (40×). (B)
Immature neuroglia focus composed of neuroblastic cells (200×). A few pigmented cells within rosettes are present and may represent
early retinal anlagen (arrows). (C) Mature neuroglia containing both neurons and glial cells. A remnant of a testicular tubule is present
in the upper right (200×). (D) Mature ganglion (100×). (E) Well-developed skin with adnexal structures and hair follicles extending deep
into the surrounding adipose tissue (20×). (F) Mature smooth muscle with a developing myenteric plexus containing immature ganglion
cells (arrow) (200×). (G) Immature smooth muscle surrounding an immature gland (100×). (H) Immature skeletal muscle showing
multinucleated myotubes and rhabdomyoblasts within cellular stroma (400×). (I) Mature skeletal muscle composed of long striated
myofibers (400×). (J) Mature skeletal muscle comprising a large area of tissue in the 3106 line (100×). (K) Focus of immature adipose
tissue. Note the variably sized individual adipocytes and lipoblasts with centrally located nuclei (arrows) (200×). (L) Mature adipose
tissue showing a lobule adjacent to bone (right) (100×). Note the generally uniform size of adipocytes. (M) Cellular immature
mesenchyme seen beneath developing epithelium (top right) (200×). The cells have spindle-shape nuclei and scattered mitoses. (N)
Fibromuscular stroma (200×). (O) Mature bone without bone marrow (100×). (P) Immature gland surrounded by immature smooth
muscle. Some glandular cells show apical clear cytoplasm (100×). (Q) Collection of immature ectactic glands some with a staghorn
appearance surrounded by immature smooth muscle/fibromuscular stroma. This collection resembles immature prostate tissue
(100×). (R) Isolated immature gland showing a few early epithelial buddings (100×). (S) Immature gland composed of stratified
cuboidal epithelium with hint of a basal layer. Note adjacent cartilage (100×). (T) Focus of immature tissue resembling yolk sac. Many
of the cells have sub- and supranuclear cytoplasmic clearing (piano keys) (100×). (U) Pigmented cells lining a glandular space (400×).
(V) Glands resembling salivary gland near an epithelial structure (duct) (lower right) (200×). (W) Intimately associated nerve and
muscle resembling a rare pathological entity seen in young children; neuromuscular hamartoma (100×). (X, Y) Developing tooth seen in
3106. X shows immature tooth organ with central pulp (P) surrounded by dentin layer (D) and ameloblastic epithelium (Am) (100×). (Y)
Tooth bell from same teratoma (20×).
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Figure 2 Tumor derived from 106-A1 and A2 lines. A–C are hematoxylin and eosin-stained images of the tumor. In panel A, many
areas showed glandular profiles composed of cells with basally oriented nuclei and abundant amphophilic cytoplasm (200×). Focal
areas showed cells with a more clear or vacuolated cytoplasm (B) (100×). C shows higher magnification view of glandular profile.
Scattered apoptotic debris is present (400×). A selected immunohistochemistry profile is shown in panels D–H. Tumor cells were
positive for both cytokeratin and vimentin (D and E, respectively, 200×). Smooth muscle actin and all muscle actin stains highlighted
scattered spindle cells interspersed between glandular profiles. Focal light staining of some glandular cells was also seen (F, smooth
muscle actin, 200×; G, all muscle actin, 400×). S100 stain (H) showed a rare positive interglandular cell (arrows) (S100; 400×).
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Figure 4 shows a histological section coregistered with a 2D
MRM slice. Structures and tissues that could be identified
from MRM images with little or no ambiguity were adipose
tissue, cyst, cartilage, and epidermal lining. A series of
coregistrations similar to that shown in Figure 4 were used to
determine which teratoma tissue types and structures were
identifiable using MRM. About 30% of attempted slice
registrations were successful, while the rest lacked compel-
ling and unambiguous correlation between the two imaging
modalities since few landmark features were present in
disorganized teratomas. Successful registrations, especially
when aided by fiduciary markers (Fig. 5F, see Supplemental
Movies for 3D rendering and orthogonal slices), allowed
homogeneous tissue patches in histology to be correlated
with pixel intensity values in T2-weighted images. Table 2
shows the results of this series of cross-teratoma correla-
tions. Tissues with low intensity in MR images, defined as 3–
22% of maximum (cyst) intensity, included adipose and
necrotic tissues, mature bone/cartilage, and neuroecto-
derm. Tissues with medium intensity (22–52% of maximum
intensity) included neuroectoderm, immature bone/carti-
lage, skin, muscle, connective, gastrointestinal, and necrot-
ic tissues. High-intensity tissues (53–100% of maximum
intensity) were limited to cystic lining/fluid and gastroin-
testinal lining. Notably, because these MR image intensity
categories (i.e., low, medium, and high) were found to
represent multiple tissue types in histology, MR images were
not able to unambiguously label any tissue types except for
adipose tissue, cyst, and calcified bone/cartilage. These
tissue types were unambiguous due to their texture features.
For example, although adipose tissue deposits and mature
(calcified) bone/cartilage are both low intensity in MR
images, adipose deposits tended to have poorly delineatedboundaries, while bone/cartilage exhibited shard-like pat-
terns. High-intensity cysts had bulging shapes with well-
delineated linings.
Previously, clinical T2-weighted MR images also identified
adipose tissue as low intensity, cyst as high intensity, and
calcification (which increases with bone/cartilage maturity)
as low intensity with shard-like textures (Yamaoka et al.,
2003; Monteiro et al., 2002; Guo et al., 2007). High-resolution
MRM was critical for enabling correlation between MR image
intensity with tissue type (Table 2); lower resolution images
would not have sufficed. However, these higher resolutions
did not allow us to uniquely identify any additional tissue
types directly from MR images, when compared with previous
clinical imaging. Yet with further analysis, MRM may allow
direct, noninvasive identification of additional tissue types,
because they revealed textured patterns not visible in low-
resolution MRI. For example, in the three teratomas shown in
Figure 3, unidentified textures included radial patterns with
alternating dark–bright spokes, faint stacks of filamentous
parallel lines, dark finger-like projections, faint concentric
lines against bright backgrounds, and dark patches with
interior textures such as bright speckles or membrane-like
lines. Correlating these textures and other regional patterns
with the tissues they represent in histology, especially aided
by computational statistical methods, could identify addi-
tional tissue types with varying levels of confidence, directly
from MRM of teratomas.Discussion
While teratoma assays are crucial for testing pluripotency
with stem cells from human and nonhuman primates, their
study may provide important insights into development,
Figure 3 Volumetric teratoma data compiled from 3D MRM segmentation of three teratomas (rows A, B, C). From left to right: Gross
Volume represents teratoma volume including cysts and mouse tissues; Solid Tissue (gray) represents teratoma volume after removing
cysts and mouse tissues; Cyst (yellow) represents percentage of Gross Volume that is liquid-filled cyst; and Low Intensity Tissue
represents the percentage of Solid Tissue that exhibits the lowest 36±7% of MR image intensities after cross-teratoma normalization.
The 36% intensity threshold was chosen since tissues below it would tend to have structure and texture (e.g., patches, lines, and
punctate spots). The three red cylinders represent toothpicks that were inserted through the volume as fiducial markers to enhance
MRM-histological registration and correlation.
Figure 4 Histological section (left) coregistered with 2D MRM slice (right). Tissues and structures that are clearly differentiated in
both histology and MRM are outlined in color. These outlines represent adipose tissue (cyan), cartilage (orange), cystic regions (red,
yellow), toothpicks inserted as fiduciary markers (green), and epidermis from skin (blue). Some tissue patches that appear in histology
do not appear in MRMbecause either they do not generateMR contrast or their contrast was diminished due toMR image slice thickness—
because the histological section is 5 μm thick, the 180-μm-thick MR image slice represents the sum of 36 histological slices. Finally,
some of the tissue that is present in the MR image slice is missing from the histological section, which is an artifact introduced during
the sectioning process.
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Figure 5 Pipeline for MRM and histopathological analysis of teratomas derived from pedigreed nhpESCs: After isolation (A) and
several days of fixation in 10% buffered formalin, wooden fiduciary markers are inserted and the teratoma is placed in a 50-ml conical
tube with Fluorinert for MRM imaging (B, F). Representative MR images are shown in panels C, D, and E. G–I show the path for
histopathological analysis from cassette to hematoxylin and eosin-stained slide. In this case the teratoma required 12 cassettes for
submission of the entire tumor. J represents the alignment of one of the whole slide scanned images to its corresponding MR image. K
demonstrates the 3D rendering of the entire teratoma with fiduciary markers in place.
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Several pluripotent stem cell lines have been derived from
nonhuman primate blastocysts and while they have been
characterized by their immunocytochemical phenotype,
ability to differentiate into multilineage cell phenotypes in
vitro, and teratomas in vivo (some lines) (Mitalipov et al.,
2006; Pau and Wolf, 2004), to our knowledge this is the first
study that compares and characterizes in a more formal and
semiquantitative fashion the morphological landscape of
teratomas derived from related families of nhpESCs using
histological analysis and MRM.
MRI performed at resolutions b100 μm per 2D voxel has
been designated MRM, and is used as a tool for virtual
histological studies. Advancements in MRM have increased
the resolution at which biological samples are imaged to be
as low as 10–16 μm in 2D images and 20–50 μm in 3D volume
acquisitions (Tyszka et al., 2005). Many different "virtualTable 2 Regional correlation of teratoma tissue types with
T2-weighted MRI image pixel intensities
MRI image region intensity Tissue types found
Low intensity (3–22% of maximum) Adipose
Necrosis
Mature bone
Mature cartilage
Neuroectoderm
Medium intensity (22–52% of maximum) Neuroectoderm
Immature cartilage
Immature bone
Skin
Skeletal muscle
Smooth muscle
Gastrointestinal
Connective
Necrosis
High intensity (52–100% of maximum) Cystic lining
Respiratory cysts
Gastrointestinaltissue stains" can be imparted on MR histology sections by
selecting imaging parameters that take advantage of MR
contrast mechanisms (Johnson et al., 1993). MR histology is
practical for creating large 3D databases that noninvasively
depict embryonic development along with anatomical
structure annotation (Petiet et al., 2008).
MRI has been used to evaluate teratoma prognosis in both
adult and prenatal scans (Mazouni et al., 2003). Cysts appear
bright andwell defined in T2-weightedMR images (Yamaoka et
al., 2003; Monteiro et al., 2002), and fat deposits are also
reliably identifiable (Monteiro et al., 2002; Guo et al., 2007).
Because cysts are well defined, they have been used to
categorize teratomas based on different scales that qualify
their cystic fraction—from entirely cystic to solid type
(Yamaoka et al., 2003; Danzer et al., 2006). Immature or
malignant teratomas tend to have fewer and smaller cystic and
calcification components (Fujimaki et al., 1994). Calcifica-
tions frequently present as low-intensity punctate, shard-like,
or linear high-density strands (Guo et al., 2007). In MR images,
solid portions of teratomas exhibit heterogeneous contrast in
both T1-weighted and T2-weightedMR images (Yamaoka et al.,
2003; Huisman et al., 2005; Fujimaki et al., 1994). MRI was
found to be superior to sonography for determining the extent
of echogenic solid-type teratomas, their content, and their
compressive effects on organs (Danzer et al., 2006).
The volumetric teratoma data obtained by MRMwas found
to have both advantages and disadvantages compared to
histology. MRM can deliver accurate volumetric measure-
ments because true 3D images are obtained, and the sample
is unaltered by histological processing. With histological
sectioning, tissue is discarded, and consequently volume
information is discarded as well. Both MRM and histological
analysis methods have the potential to introduce artifacts,
but in our study neither MRM nor histological artifacts
prevented comparison and identification of structures.
Histology offers more detail than MR microscopy, but once
sectioning is done, 3D volumetric information is lost.
Advantages of volumetric data include the ability to section
in any plane desired, perform 3D measurements, and
quantify accurate tissue fractions, such as for cyst, which
has been used to classify teratomas in the clinic (Yamaoka
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focusing on the same tissue target using different perspec-
tives and landmarks. Additionally, many of the artifacts that
are potentially introduced by histology can be avoided with
MRM, such as tissue shrinkage, wrinkles, and other cutting
deformities. MRM introduced some artifacts; most notably
fluid-filled channels such as intestinal lining showed up dark,
instead of bright in images. This is likely caused by the
difference in magnetic susceptibility between the fluid and
its adjacent tissue, causing loss of signal in T2-weighted
images. T1-weighted images were also tested, but were
found to generate unsatisfactory levels of contrast between
tissues, given image quality and signal-to-noise levels.
However, T1 weighting did appear to generate different
contrasting effects for tissues compared to T2 weighting, so
it may be useful in future studies as an additional "virtual
tissue stain."
Image registration between MRM and histology required
vigilant sample alignment, but allowed for correlation
between MR image intensity values and histological tissue
types. At a high MRM voxel resolution of 100×50 μm, only
calcified, adipose, and cystic tissues were identifiable based
on MR intensity values and tissue textures—other tissue types
shared similar intensity values and textures, and therefore
were not able to be confidently identified. When compared to
relatively low-resolution clinical MRM scans, no additional
tissue types were identifiable when using MRM. Computational
textural and shape analysis trained over many teratomas, as
well as higher resolutions, may offer improved tissue identi-
fication by better resolving and considering textures.
Careful microscopic inspection of each block of serially
sectioned teratoma tumors processed by routine histological
methods revealed a wide range of tissue types whose origins
derive from one of the three germ layers. We identified the
majority of tissue types from the H&E slides without the need
for ancillary studies. We emphasize two critical aspects of the
histopathological analysis that allow for optimal examination
of teratomas. One, we underscore the importance of having
well-processed and well-stained H&E sections. Well-pro-
cessed tissue includes having the entire teratoma well fixed
(several days), serially sectioned at 2–3 mm, and processed
so that it is free of tissue drying and microtome cutting
artifacts. This is particularly important since generally
speaking, these tumors are large, thus generating a tissue
section with a large cross-sectional area compared to a small
tissue biopsy. We recommend using a regressive H&E stain as
outlined in Supplemental Document 1. We believe that this
achieves greater nuclear detail and less interference from
staining of cytoplasmic nucleic acids. Two, it is essential to
have a versatile and experienced pathologist examine all of
the tissue sections of the tumor carefully. The pathologist
should be comfortable with the microscopic examination of a
wide variety of organ systems including perinatal and/or
pediatric specimens and experienced in identifying seemingly
inconsequential structures within the milieu of tissues
present. Perinatal and/or pediatric clinical pathology dis-
ciplines tend to have specimens that include fetal organs,
organs with developmental arrest/neoplasia, extraembryonic
tissues, and clinical teratomas. We were able to semiquantify
each tissue type to show similarities and differences in germ
layer composition and correlate some specific tissue types
with MRM.There are some limitations in this study. One is the
semiquantification of the tissue types and in related fashion
semiquantification in two dimensions. The process of
semiquantification of these relatively few teratomas was a
time-consuming and ultimately imprecise process, hence the
estimations of percentage ranges used for scoring each
representative slide from each block of teratoma. By its
nature the teratoma is a complex amalgamation of tissue
types that are in close approximation to one another often
without distinct boundaries. For example, areas of striated
muscle (immature and mature) could be seen intermingled
with the bland but prevalent mesenchymal stroma, making
exact quantification of these two distinct tissues very
difficult unless present uniformly over a reasonably large
microscopic area. Quantification of tissue types and struc-
tures in three dimensions would add additional important
information, most notably, the relationships of tissue and
developing organs to one another. To these ends, the ability
to automatically identify and segment specific tissue types
and reconstruct them in three dimensions by computerized
means would greatly advance this area of developmental
biology. Recently, our group and others have made advances
in the application of algorithms and techniques used in
automated image analysis specifically applied to recognition
of tissue types in teratomas (Oh et al., 2009; Chebira et al.,
2008). The use of numerous immunohistochemical markers
would aid quantitative analysis of specific tissue types (and
hence germ layer derivation), although we suspect that some
tissues, particularly more undifferentiated and primitive
tissues, may not have commercially available antibodies that
would both perform adequately in formalin-fixed paraffin-
embedded tissues and also elucidate specific phenotypes.
Even with commercially available antibodies some tissues
(i.e., immature neuroglial tissue) did not stain uniformly
with neuroblastic markers (e.g., PGP9.5; not shown),
reflecting their phenotypic diversity.
In summary, MRM of teratomas likely yields useful
information when studying certain tissue type development
(i.e., fat or bone) and overall growth characteristics of the
teratoma. Teratomas, overall, demonstrate a striking
variety of tissue types derived from the three germ layers.
Teratomas derived from pedigreed nonhuman primate
embryonic stem cells may be a useful model for comparing
tissue composition in teratomas derived from ESCs of related
families as well as for studying skin, bone, adipose, and
intestinal development in light of the histopathological and
MRM findings. As techniques improve in MRM and image
analysis, more tissue derivatives will be able to be identified
using noninvasive means. The MRM platform will allow for
longitudinal study of teratoma development in vivo perhaps
using labeled ESCs capable of being tracked by MRM. The
techniques and analysis presented provide for a rigorous and
standardized approach for examination and reporting of
teratomas derived from embryonic stem cells.Methods
Teratoma formation
Stem cells have been derived as described previously by
Navara et al. (2007). For this study we used a number of
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Fig. 1). A family of ES lines was derived simultaneously from
the same sperm donor and the same clutch of prime quality
eggs. Stem cell pluripotency potentials are assessed by
teratoma formation in SCID mice as follows: Nonhuman
primate ESCs were isolated by scraping colonies with good
morphology followed by a brief 5 min treatment with 0.25%
trypsin/EDTA to break up large fragments. Cells were
pelleted at 200 g for 5 min, washed twice in sterile PBS,
and approximately 5×105–5×106 cells were injected into the
testis of 8- to 12-week-old NOD-SCID mice (The Jackson
Laboratory, Bar Harbor, ME) by modification of efferent duct
injection (Ogawa et al., 1997). The injection pipette was
advanced along the efferent duct and through the rete testes
into the interstitial space where cells were injected (using
Eppendorf Femtojet). The injection itself was monitored
with trypan blue added to the cell suspension. Tumor growth
was determined by palpation and was typically detectable by
10–12 weeks after injection. Mice were euthanized when
tumors became too bulky or impaired the ability of the
animal to ambulate, eat, or drink in a normal fashion
according to Institutional Animal Care and Use Committee
guidelines. In all, we injected 34 mice from which we
generated 27 teratomas for analysis. The overall outline of
our experiments is depicted in Figure 5. Teratomas were
extracted from mice as described (Fig. 5A) and used for MRM
examination (Figs. 5B–E) and/or histopathological examina-
tion (Figs. 5F–I). These results were used to compare
histopathology with MRM (Fig. 5J) and produce a 3-D model
in MRM (Fig. 5K).Magnetic resonance microscopy
After fixation in 10% phosphate-buffered formalin for a
minimum of 5–7 days at room temperature, teratomas were
immersed in liquid Fluorinert (3M Corporation, St. Paul, MN)
and sealed in a plastic conical tube with the smallest
reasonable radius so that MR signal from the tissue sample is
maximized (Fig. 5B). Fluorinert has no proton MRM signal,
facilitating 3D surface renderings and volume analysis. One
teratoma had three wooden (i.e., low magnetic susceptibil-
ity) fiduciary markers inserted at different angles to aid later
attempts at coregistration between MR and histological
images. The teratoma samples were then imaged using a
30 mm diameter, birdcage radiofrequency resonator in an
89-mm vertical-bore 11.7T Bruker AVANCE imaging system
(Bruker BioSpin Corporation, Billerica, MA). The sample
temperature was cooled and regulated at 12 °C, increasing
MR signal by ~4%. Image data were acquired using a T2-
weighted multislice spin-echo pulse sequence with para-
meters as follows: matrix size 512×256, TE/TR=50/2000 ms,
averages=24, and slice thickness=1.0 mm. Additionally, 3D
scans were acquired using a T2-weighted spin-echo pulse
sequence with parameters as follows: matrix size
512×256×128, TE/TR=50/2000 ms, averages=3, and voxel
size=50 μm×100 μm×180 μm. The spin-echo pulse sequence
was chosen to avoid T2⁎ magnetic field inhomogeneity
artifacts, which can be prominent at high field strengths
like 11.7 T. The TR=2000 ms value was chosen to ensure full
longitudinal magnetization recovery and generate images
with pure T2 weighting. The optimal TE value of 50 ms wasempirically determined by performing scans across a range of
TE values, finding the value that maximized image contrast
between different teratoma tissue types, while also remain-
ing short enough to retain satisfactory MR image quality (i.e.,
signal-to-noise ratio). T1-weighted images were also tested,
but were found to generate unsatisfactory levels of contrast
between tissues.
MRM 3D volume rendering, volume statistics, and
histological correlation
All acquired teratoma MRM datasets were zero-filled to form
isotropic voxels, to facilitate rendering and volume measure-
ments. Volume data were imported into the 3D rendering
software Amira (Mercury Computer Systems, Chelmsford,
MA). The program was used to segment each teratoma into
its cystic, solid tissue, and low-intensity tissue components.
Low-intensity tissue represents the percentage of solid tissue
that exhibits the lowest 36±7% of MRM image intensities
after cross-teratoma normalization to cystic fluid, which was
found to be similarly composed across all three samples. The
36% intensity threshold was chosen since tissues below it
would tend to have structure and texture (e.g., patches,
lines, and punctate spots). The software was also used to
create histogram profiles of the teratoma, compute volu-
metric quantities for each segmented tissue type, and render
3D visualizations.
MRM datasets were correlated with histology to deter-
mine what tissue types and structures were identifiable using
MR microscopy. A series of histological slices that featured
homogeneous patches of different tissue types were manu-
ally registered with MRM datasets. For each slice that could
be successfully registered between MRM and histology, each
homogeneous patch of tissue in histology was located in MR
images, and vice versa, in order to record correlations
between tissue type and T2-weighted image intensity values.
To reduce potential error, at least three occurrences of each
tissue type were identified in order to generate correlations.
Tissue processing and imaging
Teratomas were fixed in 10% phosphate-buffered formalin
for at least 5–7 days (depending on the size of the tumor and
prior to sectioning or MRM scan) and sectioned at approxi-
mately 3-mm intervals using Thomas tissue slicer blades
(Thomas Scientific, Inc., Swedesboro, NJ) perpendicular to
the orientation of the teratoma within the conical tube used
for MRM. The tumor was sectioned from left to right and
sections were kept in orientation with respect to neighboring
sections (left cut face kept next to right cut face). Sections
were placed face down and kept in the same orientation with
respect to each other into labeled tissue cassettes and
processed on a conventional graded-alcohol tissue processor
(Tissue-Tek VIP 5, Sakura Finetek USA, Inc., Torrance, CA)
(see Supplemental Document 1 for processing protocol) and
paraffin-embedded maintaining the same orientation as
when initially sectioned. A representative 5-μm section
from each block was obtained using a microtome (Shandon
Finesse 325, Thermo Fisher Scientific, Inc., Waltham, MA),
floated out on a 40 °C water bath and picked up using
Superfrost Plus slides (Fisher Scientific Inc., Hampton, NH).
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a 60 °C oven and then stained using a regressive hematoxylin
and eosin (H&E) staining procedure (see Supplemental
Document 2 for staining protocol). Tumors were examined
microscopically by pathologists (J.A.O. and C.A.C.) and
designated as a teratoma if tissue representation from all
three germ layers was identified microscopically (see
Supplemental Table 2 for tissue derivatives from respective
germ layers). All images in this study were acquired using an
Olympus BX51 microscope equipped with UIS2 objectives
(Olympus America, Inc., Central Valley, PA) and 2-mega pixel
SPOT Insight camera (Diagnostic Instruments Inc., Sterling
Heights, MI) or Nikon 90i microscope equipped with a DS-Ri1
12 million pixel shifting camera (Nikon Instruments, Inc.,
Melville, NY).
Semiquantitative scoring of tissues derived from
germ layers
All histological sections of teratomas and lesions derived
from injections of nhpESCs derived from these two families
were reviewed by pathologists (J.A.O., C.A.C.). For those
tumors designated as teratomas, tissue derived from each of
the germ layers was semiquantitated by examining the
representative section from each block of the entirely
sectioned teratoma. Tissue types were identified and
categorized as belonging to ectoderm, mesoderm, or
endoderm and the percentage of the area of the slide
occupied by each tissue type was estimated according to the
following key: 0, no tissue present; 1, 1–20%; 2, 21–40%; 3,
41–60%; 4, 61–80%; and 5, 81–100%. The median of the
percentage range was then taken for all blocks for each
tissue type. For each germ layer, the medians representing
the percentage range of the tissue types derived from that
germ layer were summed and an overall percentage range
was assigned to that germ layer.
Immunohistochemistry
Immunohistochemical analyses were performed on the
formalin-fixed, paraffin-embedded tissue sections from the
tumor derived from the 106-A1/A2 lines. Primary antibodies
were directed against the following antigens: pancytokeratin
(epithelial marker; ectoderm) (mouse monoclonal, predi-
lute, Ventana Medical Systems, Tucson, AZ), smooth muscle
actin (mesoderm) (mouse monoclonal, 1:250, Dako Corpora-
tion, Carpinteria, CA), S100 (rabbit polyclonal, 1:100, Vector
Laboratories Inc., Burlingame, CA), vimentin (mesoderm)
(mouse monoclonal, predilute, Ventana), all muscle actin
(mesoderm) (clone HHF35, mouse monoclonal, predilute,
Ventana), PGP9.5 (ectoderm) (neuroendocrine/neuroblast
marker, mouse monoclonal, 1:25, Vector), myogenin (rhab-
domyosarcoma marker, mouse monoclonal, 1:500, Dako),
alpha-fetoprotein (endoderm) (rabbit polyclonal, 1:1000,
Dako), Oct3/4 (pluripotency marker) (rabbit polyclonal,
predilute, Biocare Medical), and p63 (epithelial progenitor/
stem cell and basal cell marker)(mouse monoclonal, clone
4A4, 1:200, LabVision). All immunohistochemical staining
was performed using appropriate antigen retrieval on a
Ventana Benchmark XT automated stainer (Ventana Medical
Systems, Tucson, AZ) (with the exception of Oct3/4 and p63)according to standardized protocols. A standard avidin–
biotin complex technique was used for detection.
Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2010.07.005.
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